Epidural administration of 2% Mepivacaine after spinal anesthesia does not prevent intraoperative nausea and vomiting during cesarean section: A prospective, double-blinded, randomized controlled trial

Intraoperative nausea and vomiting (IONV) is a common symptom during cesarean section (CS) delivery causing significant discomfort to patients. Combined spinal and epidural anesthesia (CSEA) can provide both intraoperative anesthesia and postoperative analgesia. During CSEA, it is reasonable to admi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Medicine (Baltimore) 2022-07, Vol.101 (26), p.e29709-e29709
Hauptverfasser: Kita, Takayuki, Furutani, Kenta, Baba, Hiroshi
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page e29709
container_issue 26
container_start_page e29709
container_title Medicine (Baltimore)
container_volume 101
creator Kita, Takayuki
Furutani, Kenta
Baba, Hiroshi
description Intraoperative nausea and vomiting (IONV) is a common symptom during cesarean section (CS) delivery causing significant discomfort to patients. Combined spinal and epidural anesthesia (CSEA) can provide both intraoperative anesthesia and postoperative analgesia. During CSEA, it is reasonable to administer local anesthetics to the epidural space before patient complaints to compensate for the diminished effect of spinal anesthesia. Therefore, we hypothesized that intraoperative epidural administration of 2% mepivacaine would reduce the incidence of IONV. Patients who were scheduled for elective CS were randomly allocated to 2 groups. Patients and all clinical staff except for an attending anesthesiologist were blinded to the allocation. After the epidural catheter was inserted at the T11-12 or T12-L1 interspace, spinal anesthesia was performed at the L2-3 or L3-4 interspace to intrathecally administer 10 mg of 0.5% hyperbaric bupivacaine. Twenty min after spinal anesthesia, either 5 mL of 2% mepivacaine (group M) or saline (group S) was administered through an epidural catheter. Vasopressors were administered prophylactically to keep both the systolic blood pressure ≥ 80 % of the baseline value with the absolute value ≥ 90 mm Hg and the mean blood pressure ≥ 60 mm Hg. The primary endpoint was the incidence of IONV. The secondary endpoints were degree of nausea, the degree and incidence of pain, and Bromage score. Ninety patients were randomized, and 3 patients were excluded from the final analysis. There was no significant difference in the incidence of IONV between the groups (58% in group M and 61% in group S, respectively, P = .82). In contrast, the incidence and degree of intraoperative pain in group M were significantly lower compared to group S. In addition, the incidence of rescue epidural administration of fentanyl (18% vs 47%) or mepivacaine (2.3% vs 25%) for intraoperative pain was lower in group M compared to group S. Our results indicate that epidural administration of 2% mepivacaine 20 minutes after spinal anesthesia does not reduce the incidence of IONV in CS under CSEA. However, intraoperative epidural administration of 2% mepivacaine was found to improve intraoperative pain.
doi_str_mv 10.1097/MD.0000000000029709
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9239613</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2684100285</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4505-bc82d16b54a964a2e4d8bb5b053b5462169389ba4b55412e763e0732fbbe9b3c3</originalsourceid><addsrcrecordid>eNpdkstu1TAQhiMEoqXwBEjIGyQWTfEljhMWlaq2XKQesYG1ZSeTHoOPHewkFbwhb8WEU0rBmxmP__nGnnFRPGf0hNFWvd5cnNC_i7eKtg-KQyZFXcq2rh7e8w-KJzl_oZQJxavHxYGQSikqm8Pi5-Xo-jkZT0y_c8HlKZnJxUDiQPhLsoHRLaYzLgAxwwSJ5NGFVR0gT1vIzpA-QiYhTmRMsECYiAsIiSOspAVIMHMGgxk9WeLOTS5cEyy5mg6ySWACydCtVd-QM6TEPK7bBY6RPVsPpfUu9NAfk4QUZPyAnnQRy0Tv0Z2SM_5p8WgwPsOzW3tUfH57-en8fXn18d2H87OrsqsklaXtGt6z2srKYGMMh6pvrJWWSoGxmrO6FU1rTWWlrBgHVQugSvDBWmit6MRRcbrnjrPdQd_B-lqvx-R2Jn3X0Tj970lwW30dF91y0dZMIODVLSDFbzO2Ue9c7sB77Gmcs-Z1UzEcaCNRKvbSDpuSEwx3ZRjV6yfQmwv9_yfArBf3b3iX82fqKKj2gpvocab5q59vIOktGD9tf_OkannJKedUUUZLjCgpfgFhhsL7</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2684100285</pqid></control><display><type>article</type><title>Epidural administration of 2% Mepivacaine after spinal anesthesia does not prevent intraoperative nausea and vomiting during cesarean section: A prospective, double-blinded, randomized controlled trial</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Wolters Kluwer Open Health</source><source>IngentaConnect Free/Open Access Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Kita, Takayuki ; Furutani, Kenta ; Baba, Hiroshi</creator><creatorcontrib>Kita, Takayuki ; Furutani, Kenta ; Baba, Hiroshi</creatorcontrib><description>Intraoperative nausea and vomiting (IONV) is a common symptom during cesarean section (CS) delivery causing significant discomfort to patients. Combined spinal and epidural anesthesia (CSEA) can provide both intraoperative anesthesia and postoperative analgesia. During CSEA, it is reasonable to administer local anesthetics to the epidural space before patient complaints to compensate for the diminished effect of spinal anesthesia. Therefore, we hypothesized that intraoperative epidural administration of 2% mepivacaine would reduce the incidence of IONV. Patients who were scheduled for elective CS were randomly allocated to 2 groups. Patients and all clinical staff except for an attending anesthesiologist were blinded to the allocation. After the epidural catheter was inserted at the T11-12 or T12-L1 interspace, spinal anesthesia was performed at the L2-3 or L3-4 interspace to intrathecally administer 10 mg of 0.5% hyperbaric bupivacaine. Twenty min after spinal anesthesia, either 5 mL of 2% mepivacaine (group M) or saline (group S) was administered through an epidural catheter. Vasopressors were administered prophylactically to keep both the systolic blood pressure ≥ 80 % of the baseline value with the absolute value ≥ 90 mm Hg and the mean blood pressure ≥ 60 mm Hg. The primary endpoint was the incidence of IONV. The secondary endpoints were degree of nausea, the degree and incidence of pain, and Bromage score. Ninety patients were randomized, and 3 patients were excluded from the final analysis. There was no significant difference in the incidence of IONV between the groups (58% in group M and 61% in group S, respectively, P = .82). In contrast, the incidence and degree of intraoperative pain in group M were significantly lower compared to group S. In addition, the incidence of rescue epidural administration of fentanyl (18% vs 47%) or mepivacaine (2.3% vs 25%) for intraoperative pain was lower in group M compared to group S. Our results indicate that epidural administration of 2% mepivacaine 20 minutes after spinal anesthesia does not reduce the incidence of IONV in CS under CSEA. However, intraoperative epidural administration of 2% mepivacaine was found to improve intraoperative pain.</description><identifier>ISSN: 1536-5964</identifier><identifier>ISSN: 0025-7974</identifier><identifier>EISSN: 1536-5964</identifier><identifier>DOI: 10.1097/MD.0000000000029709</identifier><identifier>PMID: 35777058</identifier><language>eng</language><publisher>United States: Lippincott Williams &amp; Wilkins</publisher><subject>Anesthesia, Obstetrical - methods ; Anesthesia, Spinal - adverse effects ; Anesthesia, Spinal - methods ; Cesarean Section - adverse effects ; Cesarean Section - methods ; Clinical Trial/Experimental Study ; Epidural Space ; Female ; Humans ; Mepivacaine ; Nausea - etiology ; Nausea - prevention &amp; control ; Pain ; Pregnancy ; Prospective Studies ; Vomiting</subject><ispartof>Medicine (Baltimore), 2022-07, Vol.101 (26), p.e29709-e29709</ispartof><rights>Lippincott Williams &amp; Wilkins</rights><rights>Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc.</rights><rights>Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc. 2022</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4505-bc82d16b54a964a2e4d8bb5b053b5462169389ba4b55412e763e0732fbbe9b3c3</citedby><cites>FETCH-LOGICAL-c4505-bc82d16b54a964a2e4d8bb5b053b5462169389ba4b55412e763e0732fbbe9b3c3</cites><orcidid>0000-0002-1893-4384</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9239613/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9239613/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,724,777,781,861,882,27905,27906,53772,53774</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35777058$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kita, Takayuki</creatorcontrib><creatorcontrib>Furutani, Kenta</creatorcontrib><creatorcontrib>Baba, Hiroshi</creatorcontrib><title>Epidural administration of 2% Mepivacaine after spinal anesthesia does not prevent intraoperative nausea and vomiting during cesarean section: A prospective, double-blinded, randomized controlled trial</title><title>Medicine (Baltimore)</title><addtitle>Medicine (Baltimore)</addtitle><description>Intraoperative nausea and vomiting (IONV) is a common symptom during cesarean section (CS) delivery causing significant discomfort to patients. Combined spinal and epidural anesthesia (CSEA) can provide both intraoperative anesthesia and postoperative analgesia. During CSEA, it is reasonable to administer local anesthetics to the epidural space before patient complaints to compensate for the diminished effect of spinal anesthesia. Therefore, we hypothesized that intraoperative epidural administration of 2% mepivacaine would reduce the incidence of IONV. Patients who were scheduled for elective CS were randomly allocated to 2 groups. Patients and all clinical staff except for an attending anesthesiologist were blinded to the allocation. After the epidural catheter was inserted at the T11-12 or T12-L1 interspace, spinal anesthesia was performed at the L2-3 or L3-4 interspace to intrathecally administer 10 mg of 0.5% hyperbaric bupivacaine. Twenty min after spinal anesthesia, either 5 mL of 2% mepivacaine (group M) or saline (group S) was administered through an epidural catheter. Vasopressors were administered prophylactically to keep both the systolic blood pressure ≥ 80 % of the baseline value with the absolute value ≥ 90 mm Hg and the mean blood pressure ≥ 60 mm Hg. The primary endpoint was the incidence of IONV. The secondary endpoints were degree of nausea, the degree and incidence of pain, and Bromage score. Ninety patients were randomized, and 3 patients were excluded from the final analysis. There was no significant difference in the incidence of IONV between the groups (58% in group M and 61% in group S, respectively, P = .82). In contrast, the incidence and degree of intraoperative pain in group M were significantly lower compared to group S. In addition, the incidence of rescue epidural administration of fentanyl (18% vs 47%) or mepivacaine (2.3% vs 25%) for intraoperative pain was lower in group M compared to group S. Our results indicate that epidural administration of 2% mepivacaine 20 minutes after spinal anesthesia does not reduce the incidence of IONV in CS under CSEA. However, intraoperative epidural administration of 2% mepivacaine was found to improve intraoperative pain.</description><subject>Anesthesia, Obstetrical - methods</subject><subject>Anesthesia, Spinal - adverse effects</subject><subject>Anesthesia, Spinal - methods</subject><subject>Cesarean Section - adverse effects</subject><subject>Cesarean Section - methods</subject><subject>Clinical Trial/Experimental Study</subject><subject>Epidural Space</subject><subject>Female</subject><subject>Humans</subject><subject>Mepivacaine</subject><subject>Nausea - etiology</subject><subject>Nausea - prevention &amp; control</subject><subject>Pain</subject><subject>Pregnancy</subject><subject>Prospective Studies</subject><subject>Vomiting</subject><issn>1536-5964</issn><issn>0025-7974</issn><issn>1536-5964</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkstu1TAQhiMEoqXwBEjIGyQWTfEljhMWlaq2XKQesYG1ZSeTHoOPHewkFbwhb8WEU0rBmxmP__nGnnFRPGf0hNFWvd5cnNC_i7eKtg-KQyZFXcq2rh7e8w-KJzl_oZQJxavHxYGQSikqm8Pi5-Xo-jkZT0y_c8HlKZnJxUDiQPhLsoHRLaYzLgAxwwSJ5NGFVR0gT1vIzpA-QiYhTmRMsECYiAsIiSOspAVIMHMGgxk9WeLOTS5cEyy5mg6ySWACydCtVd-QM6TEPK7bBY6RPVsPpfUu9NAfk4QUZPyAnnQRy0Tv0Z2SM_5p8WgwPsOzW3tUfH57-en8fXn18d2H87OrsqsklaXtGt6z2srKYGMMh6pvrJWWSoGxmrO6FU1rTWWlrBgHVQugSvDBWmit6MRRcbrnjrPdQd_B-lqvx-R2Jn3X0Tj970lwW30dF91y0dZMIODVLSDFbzO2Ue9c7sB77Gmcs-Z1UzEcaCNRKvbSDpuSEwx3ZRjV6yfQmwv9_yfArBf3b3iX82fqKKj2gpvocab5q59vIOktGD9tf_OkannJKedUUUZLjCgpfgFhhsL7</recordid><startdate>20220701</startdate><enddate>20220701</enddate><creator>Kita, Takayuki</creator><creator>Furutani, Kenta</creator><creator>Baba, Hiroshi</creator><general>Lippincott Williams &amp; Wilkins</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-1893-4384</orcidid></search><sort><creationdate>20220701</creationdate><title>Epidural administration of 2% Mepivacaine after spinal anesthesia does not prevent intraoperative nausea and vomiting during cesarean section: A prospective, double-blinded, randomized controlled trial</title><author>Kita, Takayuki ; Furutani, Kenta ; Baba, Hiroshi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4505-bc82d16b54a964a2e4d8bb5b053b5462169389ba4b55412e763e0732fbbe9b3c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Anesthesia, Obstetrical - methods</topic><topic>Anesthesia, Spinal - adverse effects</topic><topic>Anesthesia, Spinal - methods</topic><topic>Cesarean Section - adverse effects</topic><topic>Cesarean Section - methods</topic><topic>Clinical Trial/Experimental Study</topic><topic>Epidural Space</topic><topic>Female</topic><topic>Humans</topic><topic>Mepivacaine</topic><topic>Nausea - etiology</topic><topic>Nausea - prevention &amp; control</topic><topic>Pain</topic><topic>Pregnancy</topic><topic>Prospective Studies</topic><topic>Vomiting</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kita, Takayuki</creatorcontrib><creatorcontrib>Furutani, Kenta</creatorcontrib><creatorcontrib>Baba, Hiroshi</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Medicine (Baltimore)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kita, Takayuki</au><au>Furutani, Kenta</au><au>Baba, Hiroshi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Epidural administration of 2% Mepivacaine after spinal anesthesia does not prevent intraoperative nausea and vomiting during cesarean section: A prospective, double-blinded, randomized controlled trial</atitle><jtitle>Medicine (Baltimore)</jtitle><addtitle>Medicine (Baltimore)</addtitle><date>2022-07-01</date><risdate>2022</risdate><volume>101</volume><issue>26</issue><spage>e29709</spage><epage>e29709</epage><pages>e29709-e29709</pages><issn>1536-5964</issn><issn>0025-7974</issn><eissn>1536-5964</eissn><abstract>Intraoperative nausea and vomiting (IONV) is a common symptom during cesarean section (CS) delivery causing significant discomfort to patients. Combined spinal and epidural anesthesia (CSEA) can provide both intraoperative anesthesia and postoperative analgesia. During CSEA, it is reasonable to administer local anesthetics to the epidural space before patient complaints to compensate for the diminished effect of spinal anesthesia. Therefore, we hypothesized that intraoperative epidural administration of 2% mepivacaine would reduce the incidence of IONV. Patients who were scheduled for elective CS were randomly allocated to 2 groups. Patients and all clinical staff except for an attending anesthesiologist were blinded to the allocation. After the epidural catheter was inserted at the T11-12 or T12-L1 interspace, spinal anesthesia was performed at the L2-3 or L3-4 interspace to intrathecally administer 10 mg of 0.5% hyperbaric bupivacaine. Twenty min after spinal anesthesia, either 5 mL of 2% mepivacaine (group M) or saline (group S) was administered through an epidural catheter. Vasopressors were administered prophylactically to keep both the systolic blood pressure ≥ 80 % of the baseline value with the absolute value ≥ 90 mm Hg and the mean blood pressure ≥ 60 mm Hg. The primary endpoint was the incidence of IONV. The secondary endpoints were degree of nausea, the degree and incidence of pain, and Bromage score. Ninety patients were randomized, and 3 patients were excluded from the final analysis. There was no significant difference in the incidence of IONV between the groups (58% in group M and 61% in group S, respectively, P = .82). In contrast, the incidence and degree of intraoperative pain in group M were significantly lower compared to group S. In addition, the incidence of rescue epidural administration of fentanyl (18% vs 47%) or mepivacaine (2.3% vs 25%) for intraoperative pain was lower in group M compared to group S. Our results indicate that epidural administration of 2% mepivacaine 20 minutes after spinal anesthesia does not reduce the incidence of IONV in CS under CSEA. However, intraoperative epidural administration of 2% mepivacaine was found to improve intraoperative pain.</abstract><cop>United States</cop><pub>Lippincott Williams &amp; Wilkins</pub><pmid>35777058</pmid><doi>10.1097/MD.0000000000029709</doi><orcidid>https://orcid.org/0000-0002-1893-4384</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1536-5964
ispartof Medicine (Baltimore), 2022-07, Vol.101 (26), p.e29709-e29709
issn 1536-5964
0025-7974
1536-5964
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9239613
source MEDLINE; DOAJ Directory of Open Access Journals; Wolters Kluwer Open Health; IngentaConnect Free/Open Access Journals; EZB-FREE-00999 freely available EZB journals; PubMed Central; Alma/SFX Local Collection
subjects Anesthesia, Obstetrical - methods
Anesthesia, Spinal - adverse effects
Anesthesia, Spinal - methods
Cesarean Section - adverse effects
Cesarean Section - methods
Clinical Trial/Experimental Study
Epidural Space
Female
Humans
Mepivacaine
Nausea - etiology
Nausea - prevention & control
Pain
Pregnancy
Prospective Studies
Vomiting
title Epidural administration of 2% Mepivacaine after spinal anesthesia does not prevent intraoperative nausea and vomiting during cesarean section: A prospective, double-blinded, randomized controlled trial
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-21T05%3A14%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Epidural%20administration%20of%202%25%20Mepivacaine%20after%20spinal%20anesthesia%20does%20not%20prevent%20intraoperative%20nausea%20and%20vomiting%20during%20cesarean%20section:%20A%20prospective,%20double-blinded,%20randomized%20controlled%20trial&rft.jtitle=Medicine%20(Baltimore)&rft.au=Kita,%20Takayuki&rft.date=2022-07-01&rft.volume=101&rft.issue=26&rft.spage=e29709&rft.epage=e29709&rft.pages=e29709-e29709&rft.issn=1536-5964&rft.eissn=1536-5964&rft_id=info:doi/10.1097/MD.0000000000029709&rft_dat=%3Cproquest_pubme%3E2684100285%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2684100285&rft_id=info:pmid/35777058&rfr_iscdi=true